Nature publication: Whole-genome landscapes of 1,364 breast cancers
Dr. Erin Connolly-Strong, PhD | Chief Medical Officer
March 10, 2026 9 AM PT
Register for our upcoming webinar of our Nature publication: Whole-genome landscapes of 1,364 breast cancers
Join our webinar to explore more insights of this ground breaking publication and learn how Whole-Genome Sequencing (WGS) is reshaping biological understanding and therapeutic decision-making:
- WGS–informed HRD classification challenges traditional HRD definitions—delivering clearer separation of HR-deficient and HR-proficient tumors and deeper insight into therapy response biology
- WGS improves CNV determination for HER2+ breast cancer, by capturing complex copy-number architecture, including ecDNA
- WGS reveals that NRG1 and other recurrent fusions occur more frequently than previously recognized in breast cancer — opening the door to more therapeutic alternatives
- WGS reveals meaningful genomic differences within clinically similar breast cancer subtypes—differences that may inform more precise treatment strategies.
At Inocras, we believe precision oncology begins with a complete view of the genome, moving beyond limited biomarkers to unlock more precise, data-driven approaches.
About the speaker:
Erin serves as the Chief Medical Officer at Inocras, overseeing medical affairs, clinical study design, and market access strategy. With a Ph.D. in Biomedical Science from Albert Einstein College of Medicine, Erin has held pivotal roles in pharmaceutical, biotech, and diagnostics companies, including notable positions at Scipher and Mallinckrodt.
She leads the development of clinical research to validate Inocras’ technology, utilizing her expertise to advance precision medicine. Erin is recognized for her leadership and commitment to enhancing patient outcomes.